उत्पाद विवरण
Siropan 1 mg Tablet is an essential medication designed to support patients undergoing organ transplantation and to manage lymphangioleiomyomatosis (LAM), a rare lung disease. Belonging to the class of mTOR inhibitors, Siropan works by modulating the immune response, effectively preventing the body from rejecting transplanted organs. This targeted approach not only enhances the success of transplants but also provides relief for those affected by LAM. While using Siropan 1 mg Tablet, patients may experience some common side effects, including fatigue and gastrointestinal discomfort. It is crucial to monitor kidney function and other health parameters during treatment, as this medication can affect overall health. Always consult with a healthcare professional before starting or adjusting your dosage to ensure optimal safety and efficacy. Siropan serves as a vital tool in the management of transplant rejection and specific lung conditions, helping patients lead healthier lives. With its focused action and ongoing monitoring, Siropan 1 mg Tablet represents a significant advancement in therapeutic options.